Table 6.
Testing known exposed children3 |
Universal testing of all children |
|||
---|---|---|---|---|
Outcome | Anti-HCV with reflex to HCV RNA at 18 months4 (Comparison) |
HCV RNA test at 2-6 months5 (Test Strategy 1) |
Anti-HCV with reflex to HCV RNA at 18 months4,6 (Test Strategy 2) |
HCV RNA test at 2-6 months5,7 (Test Strategy 3) |
Total costs (2021 USD) | 80,058,982 | 82,265,899 | 122,475,587 | 219,378,669 |
Testing outcomes | ||||
Tested children | 4,478 | 7,588 | 2,709,916 | 3,076,918 |
Anti-HCV tests | 4,478 | 0 | 2,709,916 | 0 |
HCV RNA tests | 391 | 7,588 | 6,254 | 3,076,918 |
Epidemiologic outcomes among perinatally exposed children | ||||
Diagnosed HCV infections | 315 | 555 | 690 | 1,214 |
HCC cases | 410 | 335 | 306 | 146 |
DCC cases | 449 | 375 | 322 | 151 |
Liver transplants | 75 | 62 | 55 | 27 |
HCV Liver-related deaths | 736 | 607 | 533 | 251 |
Treated/cured HCV infections | 489 | 637 | 724 | 1,052 |
Total QALYs | 691,536 | 692,465 | 692,998 | 695,033 |
Total Life-years | 1,807,966 | 1,812,814 | 1,815,616 | 1,826,263 |
Assumes 3.6 million births with 0.64% of births occurring among persons who are HCV RNA+.
Assuems prevalence of HCV infection among children perinatally exposed is 7.2% and 20.9% of children that are treated at age 3 would have spontaneous cleared infection without treatment.
References:
Ades AE, Gordon F, Scott K, Collins IJ, Thorne C, Pembrey L, Chappell E, Marine-Barjoan E, Butler K, Indolfi G, Gibb DM, Judd A. Overall vertical transmission of HCV, transmission net of clearance, and timing of transmission. Clin Infect Dis. 2022 Apr 11:ciac270. doi: 10.1093/cid/ciac270. Epub ahead of print. PMID: 35403676
Ades AE, Gordon F, Scott K, Collins IJ, Thorne C, Pembrey L, Chappell E, Marine-Barjoan E, Butler K, Indolfi G, Gibb DM, Judd A. Spontaneous Clearance Of Vertically Acquired Hepatitis C Infection: Implications For Testing And Treatment. Clin Infect Dis. 2022 Apr 9:ciac255. doi: 10.1093/cid/ciac255. Epub ahead of print. PMID: 35396848.
Assumes 44.7% of all pregnant persons are screened for HCV infection.
Assumes 43.0% of children born to HCV RNA+ pregnant persons attend an 18-month visit.
Assumes 73.5% of children born to HCV RNA+ pregnant persons attend a 2-6 month visit.
Assumes 75.0% of children born to pregnant persons without HCV attend an 18-month visit.
Assumes 85.0% of children born to pregnant persons without HCV attend a 2-6 month visit.
Abbreviations: HCV, hepatitis C virus; anti-HCV, hepatitis C virus antibody; HCC, hepatocellular carcinoma; DCC, decompensated cirrhosis; USD, United States Dollars; QALYs, quality-adjusted life-years.